Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure

Journal of Glaucoma

Volumn 8, Issue 2, 1999, Pages 117-123

  Koseki, N ^a   Araie, M ^a   Yamagami, J ^a   Shirato, S ^a   Yamamoto, S ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Brovincamine; Linear mixed model; Normal tension glaucoma; Prospective follow up; Visual field performance

Indexed keywords

BROVINCAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; STATISTICAL MODEL; VISION TEST; VISUAL FIELD; VISUAL FIELD DEFECT;

EID: 0033278165     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-199904000-00006     Document Type: Article

References (39)

1. Mechanism of optic nerve damage in primary open angle glaucoma
2. Progressive low-tension glaucoma: Treatment to stop glaucomatous cupping and field loss when these progress despite normal intraocular pressure
3. Results of filtering procedure in low tension glaucoma
4. Trabeculectomy for normal-tension glaucoma
5. Surgery for normal tension glaucoma
6. Diurnal variation of intraocular pressure of normal-tension glaucoma
7. Diurnal variation in intraocular pressure of normal-tension glaucoma eyes
8. The vascular concept of glaucoma
9. Epidemiology of glaucoma in Japan: A nationwide glaucoma survey
10. The influence of the intraocular pressure on the visual field of low tension glaucoma
11. Do vasospasms help cause low tension glaucoma?
12. Influence of vasospasm on visual function
13. 2+-antagonist on visual field in low-tension glaucoma
14. Calcium channel blockers in the management of low-tension and open-angle glaucoma
15. Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma and in control subjects
16. Lack of effect of calcium channel blockers on open-angle glaucoma
17. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma
18. Cardiovascular effects of brovincamine and possible mechanism involved
19. Calcium antagonistic action involved in vasodilation by brovincamine
20. Clinical utility of brovincamine and dihydroergotoxine in senile and presenile cases with organic brain syndrome
21. Systemic blood pressure in glaucoma patients
22. Diurnal and nocturnal blood pressure drops in patients with focal ischemic glaucoma
23. Ambulatory blood pressure monitoring in glaucoma: The nocturnal dip
24. Determining progressive visual field loss in serial Humphrey visual fields
25. Analysis of progressive change in automated visual fields in glaucoma
26. Random effects models for longitudinal data
27. Parapapillary chorioretinal atrophy in normal and glaucoma eyes. II. Correlations
28. Low tension glaucoma: A critical review and new material
29. Low tension glaucoma: Its place in modern glaucoma practice
30. Intraocular pressure, glaucoma, and glaucoma suspects in a defined population
31. The prevalence of glaucoma
32. Prevalence of glaucoma: The Beaver Dam Eye Study
33. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population: The Rotterdam Study
34. Visual field change in low-tension glaucoma over a five-year follow-up
35. Regression analysis of visual field progression in low tension glaucoma
36. Factors contributing to the progression of visual field damage in eyes with normal tension glaucoma
37. Medical treatment for normal-tension glaucoma